Northern Gritstone

Northern Gritstone invests in Manchester spinout Apini

Northern Gritstone has committed £1.8 million to Apini, a spinout from the University of Manchester Apini is a novel small molecule therapeutic programme for the treatment of multiple chronic inflammatory diseases such as Crohn’s and Ulcerative Colitis Commitment follows existing Syncona investment as part of its accelerator Slingshot Therapeutics. 11 June 2025 -- Manchester, UK...
No.1 Circle Square 3 Symphony Park Manchester M1 7FS